Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain EBS message board posts where the ticker symbol EBS has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest EBS SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001567619-18-007116 Size: 23 KB
2018-11-29
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-029754 Size: 9 KB
2018-11-28
CT ORDER  Documents Confidential treatment order
Acc-no: 9999999997-18-009112 (34 Act)  Size: 107 KB
2018-11-27 001-33137
181201507
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-029546 Size: 9 KB
2018-11-21
CT ORDER  Documents Confidential treatment order
Acc-no: 9999999997-18-008948 (34 Act)  Size: 107 KB
2018-11-13 001-33137
181170182
CT ORDER  Documents Confidential treatment order
Acc-no: 9999999997-18-008947 (34 Act)  Size: 107 KB
2018-11-13 001-33137
181170066
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001567619-18-005458 Size: 6 KB
2018-11-08
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001567619-18-005447 Size: 8 KB
2018-11-08
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001567619-18-005434 Size: 4 KB
2018-11-08
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001567619-18-005431 Size: 4 KB
2018-11-08
More EBS SEC Filings


Related news from
Tue, 11 Dec 2018
13:05:30 +0000
See what the IHS Markit Score report has to say about Emergent Biosolutions Inc.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Wed, 05 Dec 2018
17:22:55 +0000
Read This Before Judging Emergent BioSolutions Inc’s (NYSE:EBS) ROE
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it Read More...
Tue, 04 Dec 2018
13:15:00 +0000
Detailed Research: Economic Perspectives on United Technologies, Walmart, Invitae, Emergent Biosolutions, U.S. Physical Therapy, and Amdocs — What Drives Growth in Today's Competitive Landscape
NEW YORK, Dec. 04, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Sat, 01 Dec 2018
14:31:02 +0000
Emergent Biosolutions (EBS) Up 14.1% Since Last Earnings Report: Can It Continue?
Emergent Biosolutions (EBS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tue, 20 Nov 2018
14:10:02 +0000
Emergent's (EBS) Zika Vaccine Candidate Meets Study Endpoint
Emergent BioSolutions (EBS) and partner Valneva present positive data from an early-stage study on the Zika vaccine candidate, VLA1601.
Mon, 19 Nov 2018
22:05:53 +0000
Emergent-Valneva Zika vaccine clears early trial
A vaccine to prevent infections caused by the deadly mosquito-borne Zika virus induced immune response and was found to be safe in an early stage trial, Emergent BioSolutions Inc and partner Valneva SE said on Monday. The vaccine, VLA1601, which was tested in two doses in 67 adult patients, induced the body to produce neutralizing antibodies against the virus, the companies said. First discovered in 1947, the Zika virus reached epidemic proportions in Brazil in 2015, when thousands of babies were born with birth defects.
Mon, 19 Nov 2018
21:22:22 +0000
Emergent BioSolutions and Valneva Report Positive Phase 1 Results for Their Vaccine Candidate Against the Zika Virus
GAITHERSBURG, Md. and SAINT-HERBLAIN, France, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (EBS) and Valneva SE (VLA) today announced positive interim results for the Phase 1 study evaluating VLA1601, their vaccine candidate against the Zika virus. The highly purified inactivated vaccine candidate, VLA1601, met the study’s primary endpoint showing a favorable safety profile in all doses and schedules tested. VLA1601 was also immunogenic in all treatment groups and induced both dose- and schedule-dependent neutralizing antibodies against the Zika virus with the kinetics expected for an inactivated, alum-adjuvanted whole-virus vaccine.
Mon, 19 Nov 2018
21:16:02 +0000
EMERGENT BIOSOLUTIONS AND VALNEVA REPORT POSITIVE PHASE 1 RESULTS FOR THEIR VACCINE CANDIDATE AGAINST THE ZIKA VIRUS
GAITHERSBURG, Md. and Saint-Herblain, France, November 19, 2018 - Emergent BioSolutions Inc. (EBS) and Valneva SE (VLA) today announced positive interim results for the Phase 1 study evaluating VLA1601, their vaccine candidate against the Zika virus. The highly purified inactivated vaccine candidate, VLA1601, met the study`s primary endpoint showing a favorable safety profile in all doses and schedules tested. VLA1601 was also immunogenic in all treatment groups and induced both dose- and schedule-dependent neutralizing antibodies against the Zika virus with the kinetics expected for an inactivated, alum-adjuvanted whole-virus vaccine.
Fri, 09 Nov 2018
16:27:23 +0000
Edited Transcript of EBS earnings conference call or presentation 1-Nov-18 9:00pm GMT
Q3 2018 Emergent BioSolutions Inc Earnings Call
Tue, 06 Nov 2018
20:39:00 +0000
Emergent BioSolutions Nabs Its Acquisition (Times 2)
The bioterrorism-response company expands externally.
Tue, 06 Nov 2018
12:00:00 +0000
Emergent BioSolutions to Participate in Series of Near-Term Investor Conferences
GAITHERSBURG, Md., Nov. 06, 2018 -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will participate in the.
Fri, 02 Nov 2018
16:54:04 +0000
Emergent (EBS) Q3 Earnings and Revenues Fall Shy of Estimates
Emergent (EBS) disappoints with weaker-than-expected results in the third quarter of 2018.
Fri, 02 Nov 2018
11:30:11 +0000
Emergent Biosolutions (EBS) Q3 Earnings and Revenues Lag Estimates
Emergent Biosolutions (EBS) delivered earnings and revenue surprises of -11.29% and -7.73%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Fri, 02 Nov 2018
09:07:37 +0000
Emergent Biosolutions: 3Q Earnings Snapshot
On a per-share basis, the Gaithersburg, Maryland-based company said it had net income of 41 cents. Earnings, adjusted for one-time gains and costs, were 55 cents per share. The results missed Wall Street ...
Fri, 02 Nov 2018
06:42:00 +0000
European markets rise on hopes of a US-China trade agreement; banks in the spotlight
European markets rise on hopes of a US-China trade agreement; banks in the spotlight
Fri, 02 Nov 2018
01:33:17 +0000
Emergent BioSolutions Inc (EBS) Q3 2018 Earnings Conference Call Transcript
EBS earnings call for the period ending September 30, 2018.
Thu, 01 Nov 2018
20:30:00 +0000
Emergent BioSolutions Reports Financial Results for Third Quarter and Nine Months of 2018
Q3 2018 performance in line with guidanceRevises full year 2018 financial forecast to reflect anticipated strong full year organic business performance, expected at the higher.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "No friend, no book, no broker, no advisor, no expert has ever provided a tenth what I am able to find here. The best money I have EVER spent, is for membership." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards